Literature DB >> 28222836

Presumptive Spontaneous Lysosomal Storage-Like Disease in a Crl:CD1(ICR) Mouse.

Krista M Hernon1, Tiffany L Whitcomb2, Lori Davis2, Timothy K Cooper3.   

Abstract

A clinically unremarkable 4.5-mo-old female Crl:CD1(ICR) VAF/Elite mouse was euthanized for scheduled sentinel processing. Gross necropsy findings included significant hepatosplenomegaly and visceral lymphadenomegaly, resulting in a preliminary gross diagnosis of lymphoma. Histology revealed florid accumulations of large, 'foamy' macrophages present in the bone marrow, small intestines, and viscera including liver, spleen, lymph nodes, thymus, uterus, and ovaries. The cytoplasm of these cells was abundant, stained pale blue with Wright-Giemsa and was periodic acid-Schiff positive. Given these characteristic gross and histologic findings, a spontaneous lysosomal storage-like disease was diagnosed in this mouse. Cholesterol ester storage disease is likely, because of the visceral involvement with sparing of the CNS, but could not be diagnosed definitively. To our knowledge, this report is the first to describe a case of spontaneous lysosomal storage disease in an outbred mouse of the CD1(ICR) background.

Entities:  

Mesh:

Year:  2017        PMID: 28222836      PMCID: PMC5310622     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  9 in total

Review 1.  Drug-induced phospholipidosis.

Authors:  Nora Anderson; Jürgen Borlak
Journal:  FEBS Lett       Date:  2006-09-05       Impact factor: 4.124

Review 2.  Cholesteryl ester storage disease: a rare and possibly treatable cause of premature vascular disease and cirrhosis.

Authors:  Tim Reynolds
Journal:  J Clin Pathol       Date:  2013-09-02       Impact factor: 3.411

Review 3.  Lysosomal storage diseases of animals: an essay in comparative pathology.

Authors:  R D Jolly; S U Walkley
Journal:  Vet Pathol       Date:  1997-11       Impact factor: 2.221

4.  Lysosomal acid lipase-deficient mice: depletion of white and brown fat, severe hepatosplenomegaly, and shortened life span.

Authors:  H Du; M Heur; M Duanmu; G A Grabowski; D Y Hui; D P Witte; J Mishra
Journal:  J Lipid Res       Date:  2001-04       Impact factor: 5.922

5.  Creation of a mouse model for non-neurological (type B) Niemann-Pick disease by stable, low level expression of lysosomal sphingomyelinase in the absence of secretory sphingomyelinase: relationship between brain intra-lysosomal enzyme activity and central nervous system function.

Authors:  S Marathe; S R Miranda; C Devlin; A Johns; G Kuriakose; K J Williams; E H Schuchman; I Tabas
Journal:  Hum Mol Genet       Date:  2000-08-12       Impact factor: 6.150

Review 6.  Types A and B Niemann-Pick disease.

Authors:  Edward H Schuchman; Melissa P Wasserstein
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2014-10-16       Impact factor: 4.690

Review 7.  Gene therapy for lysosomal storage diseases (LSDs) in large animal models.

Authors:  Mark Haskins
Journal:  ILAR J       Date:  2009

8.  Early occurrence of spontaneous tumors in CD-1 mice and Sprague-Dawley rats.

Authors:  Woo-Chan Son; Chirukandath Gopinath
Journal:  Toxicol Pathol       Date:  2004 Jul-Aug       Impact factor: 1.902

9.  Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease.

Authors:  K Horinouchi; S Erlich; D P Perl; K Ferlinz; C L Bisgaier; K Sandhoff; R J Desnick; C L Stewart; E H Schuchman
Journal:  Nat Genet       Date:  1995-07       Impact factor: 38.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.